MassMutual Private Wealth & Trust’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Other funds holding SUPN
HWAM
WCM
YIH
FSA
EA
YCM
CWP
QCM
MassMutual Private Wealth & Trust's SUPN Position: Q2 2026 in Review
MassMutual Private Wealth & Trust held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 292 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1265.
MassMutual Private Wealth & Trust first reported a position in SUPN in Q1 2018 and has held it in 22 quarters since. The position peaked at $16.5K in Q4 2025. 27 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- MassMutual Private Wealth & Trust held 292 shares of Supernus Pharmaceuticals worth $13.6K as of Q2 2026.
- MassMutual Private Wealth & Trust left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
- Supernus Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1265 holding.
- MassMutual Private Wealth & Trust first reported a position in Supernus Pharmaceuticals in Q1 2018 and has held it in 22 quarters since.
- MassMutual Private Wealth & Trust's Supernus Pharmaceuticals position peaked at $16.5K in Q4 2025.
- 27 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.